CN100351379C - Transglutaminase Gene and Its Encoded Transglutaminase from Streptomyces ladaka - Google Patents
Transglutaminase Gene and Its Encoded Transglutaminase from Streptomyces ladaka Download PDFInfo
- Publication number
- CN100351379C CN100351379C CNB011437227A CN01143722A CN100351379C CN 100351379 C CN100351379 C CN 100351379C CN B011437227 A CNB011437227 A CN B011437227A CN 01143722 A CN01143722 A CN 01143722A CN 100351379 C CN100351379 C CN 100351379C
- Authority
- CN
- China
- Prior art keywords
- seq
- ala
- transglutaminase
- gly
- glutaminases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 108060008539 Transglutaminase Proteins 0.000 title claims abstract description 61
- 102000003601 transglutaminase Human genes 0.000 title claims abstract description 47
- 241000187747 Streptomyces Species 0.000 title claims description 10
- 108020004414 DNA Proteins 0.000 claims abstract description 54
- 102000053602 DNA Human genes 0.000 claims abstract description 17
- 150000001413 amino acids Chemical class 0.000 claims description 27
- 125000003729 nucleotide group Chemical group 0.000 claims description 23
- 108090000623 proteins and genes Proteins 0.000 claims description 22
- 239000002773 nucleotide Substances 0.000 claims description 21
- 239000013604 expression vector Substances 0.000 claims description 17
- 235000001014 amino acid Nutrition 0.000 claims description 15
- 235000018102 proteins Nutrition 0.000 claims description 15
- 102000004169 proteins and genes Human genes 0.000 claims description 15
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 12
- 229920001184 polypeptide Polymers 0.000 claims description 10
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 10
- 235000013305 food Nutrition 0.000 claims description 6
- 241000894007 species Species 0.000 claims description 5
- 235000013351 cheese Nutrition 0.000 claims description 3
- 238000012545 processing Methods 0.000 claims description 3
- 238000000926 separation method Methods 0.000 claims description 3
- 239000005018 casein Substances 0.000 claims description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 2
- 235000021240 caseins Nutrition 0.000 claims description 2
- 235000021245 dietary protein Nutrition 0.000 claims description 2
- 235000013332 fish product Nutrition 0.000 claims description 2
- 235000013312 flour Nutrition 0.000 claims description 2
- 235000012041 food component Nutrition 0.000 claims description 2
- 239000005417 food ingredient Substances 0.000 claims description 2
- 239000010985 leather Substances 0.000 claims description 2
- 235000011837 pasties Nutrition 0.000 claims description 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 11
- 235000013372 meat Nutrition 0.000 claims 1
- 241001495137 Streptomyces mobaraensis Species 0.000 abstract description 4
- 239000012634 fragment Substances 0.000 description 14
- 238000000034 method Methods 0.000 description 12
- 239000013598 vector Substances 0.000 description 12
- 150000007523 nucleic acids Chemical class 0.000 description 10
- 102000039446 nucleic acids Human genes 0.000 description 9
- 108020004707 nucleic acids Proteins 0.000 description 9
- 238000003752 polymerase chain reaction Methods 0.000 description 8
- 108090000790 Enzymes Proteins 0.000 description 7
- 102000004190 Enzymes Human genes 0.000 description 6
- 108010079364 N-glycylalanine Proteins 0.000 description 6
- 241000187398 Streptomyces lividans Species 0.000 description 6
- 108010062796 arginyllysine Proteins 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 238000009396 hybridization Methods 0.000 description 5
- 239000013612 plasmid Substances 0.000 description 5
- 239000000523 sample Substances 0.000 description 5
- AXXCUABIFZPKPM-BQBZGAKWSA-N Asp-Arg-Gly Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O AXXCUABIFZPKPM-BQBZGAKWSA-N 0.000 description 4
- 108091026890 Coding region Proteins 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 108091028043 Nucleic acid sequence Proteins 0.000 description 4
- DDYIRGBOZVKRFR-AVGNSLFASA-N Phe-Asp-Glu Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N DDYIRGBOZVKRFR-AVGNSLFASA-N 0.000 description 4
- QKDIHFHGHBYTKB-IHRRRGAJSA-N Pro-Ser-Phe Chemical compound N([C@@H](CO)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C(=O)[C@@H]1CCCN1 QKDIHFHGHBYTKB-IHRRRGAJSA-N 0.000 description 4
- 108020004511 Recombinant DNA Proteins 0.000 description 4
- 241001663926 Streptotrichum Species 0.000 description 4
- 238000010367 cloning Methods 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 239000013615 primer Substances 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 238000012163 sequencing technique Methods 0.000 description 3
- YYSWCHMLFJLLBJ-ZLUOBGJFSA-N Ala-Ala-Ser Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O YYSWCHMLFJLLBJ-ZLUOBGJFSA-N 0.000 description 2
- SSSROGPPPVTHLX-FXQIFTODSA-N Ala-Arg-Asp Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(O)=O SSSROGPPPVTHLX-FXQIFTODSA-N 0.000 description 2
- TTXMOJWKNRJWQJ-FXQIFTODSA-N Ala-Arg-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)C)CCCN=C(N)N TTXMOJWKNRJWQJ-FXQIFTODSA-N 0.000 description 2
- CVGNCMIULZNYES-WHFBIAKZSA-N Ala-Asn-Gly Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O CVGNCMIULZNYES-WHFBIAKZSA-N 0.000 description 2
- LSLIRHLIUDVNBN-CIUDSAMLSA-N Ala-Asp-Lys Chemical compound C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CCCCN LSLIRHLIUDVNBN-CIUDSAMLSA-N 0.000 description 2
- SFNFGFDRYJKZKN-XQXXSGGOSA-N Ala-Gln-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](C)N)O SFNFGFDRYJKZKN-XQXXSGGOSA-N 0.000 description 2
- XYTNPQNAZREREP-XQXXSGGOSA-N Ala-Glu-Thr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O XYTNPQNAZREREP-XQXXSGGOSA-N 0.000 description 2
- ZVFVBBGVOILKPO-WHFBIAKZSA-N Ala-Gly-Ala Chemical compound C[C@H](N)C(=O)NCC(=O)N[C@@H](C)C(O)=O ZVFVBBGVOILKPO-WHFBIAKZSA-N 0.000 description 2
- HHRAXZAYZFFRAM-CIUDSAMLSA-N Ala-Leu-Asn Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O HHRAXZAYZFFRAM-CIUDSAMLSA-N 0.000 description 2
- CCDFBRZVTDDJNM-GUBZILKMSA-N Ala-Leu-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O CCDFBRZVTDDJNM-GUBZILKMSA-N 0.000 description 2
- SUHLZMHFRALVSY-YUMQZZPRSA-N Ala-Lys-Gly Chemical compound NCCCC[C@H](NC(=O)[C@@H](N)C)C(=O)NCC(O)=O SUHLZMHFRALVSY-YUMQZZPRSA-N 0.000 description 2
- PEIBBAXIKUAYGN-UBHSHLNASA-N Ala-Phe-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)C)CC1=CC=CC=C1 PEIBBAXIKUAYGN-UBHSHLNASA-N 0.000 description 2
- VQAVBBCZFQAAED-FXQIFTODSA-N Ala-Pro-Asn Chemical compound C[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)N)C(=O)O)N VQAVBBCZFQAAED-FXQIFTODSA-N 0.000 description 2
- FQNILRVJOJBFFC-FXQIFTODSA-N Ala-Pro-Asp Chemical compound C[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)O)N FQNILRVJOJBFFC-FXQIFTODSA-N 0.000 description 2
- ARHJJAAWNWOACN-FXQIFTODSA-N Ala-Ser-Val Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O ARHJJAAWNWOACN-FXQIFTODSA-N 0.000 description 2
- WNHNMKOFKCHKKD-BFHQHQDPSA-N Ala-Thr-Gly Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O WNHNMKOFKCHKKD-BFHQHQDPSA-N 0.000 description 2
- YEBZNKPPOHFZJM-BPNCWPANSA-N Ala-Tyr-Val Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(O)=O YEBZNKPPOHFZJM-BPNCWPANSA-N 0.000 description 2
- DBKNLHKEVPZVQC-LPEHRKFASA-N Arg-Ala-Pro Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](C)C(=O)N1CCC[C@@H]1C(O)=O DBKNLHKEVPZVQC-LPEHRKFASA-N 0.000 description 2
- RVDVDRUZWZIBJQ-CIUDSAMLSA-N Arg-Asn-Glu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O RVDVDRUZWZIBJQ-CIUDSAMLSA-N 0.000 description 2
- QPOARHANPULOTM-GMOBBJLQSA-N Arg-Asn-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCCN=C(N)N)N QPOARHANPULOTM-GMOBBJLQSA-N 0.000 description 2
- ZTKHZAXGTFXUDD-VEVYYDQMSA-N Arg-Asn-Thr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O ZTKHZAXGTFXUDD-VEVYYDQMSA-N 0.000 description 2
- OCOZPTHLDVSFCZ-BPUTZDHNSA-N Arg-Asn-Trp Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCCN=C(N)N)N OCOZPTHLDVSFCZ-BPUTZDHNSA-N 0.000 description 2
- HQIZDMIGUJOSNI-IUCAKERBSA-N Arg-Gly-Arg Chemical compound N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O HQIZDMIGUJOSNI-IUCAKERBSA-N 0.000 description 2
- WKPXXXUSUHAXDE-SRVKXCTJSA-N Arg-Pro-Arg Chemical compound NC(N)=NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(O)=O WKPXXXUSUHAXDE-SRVKXCTJSA-N 0.000 description 2
- ATABBWFGOHKROJ-GUBZILKMSA-N Arg-Pro-Ser Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O ATABBWFGOHKROJ-GUBZILKMSA-N 0.000 description 2
- ICRHGPYYXMWHIE-LPEHRKFASA-N Arg-Ser-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CO)NC(=O)[C@H](CCCN=C(N)N)N)C(=O)O ICRHGPYYXMWHIE-LPEHRKFASA-N 0.000 description 2
- QLSRIZIDQXDQHK-RCWTZXSCSA-N Arg-Val-Thr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O QLSRIZIDQXDQHK-RCWTZXSCSA-N 0.000 description 2
- NXVGBGZQQFDUTM-XVYDVKMFSA-N Asn-Ala-His Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CC(=O)N)N NXVGBGZQQFDUTM-XVYDVKMFSA-N 0.000 description 2
- MFFOYNGMOYFPBD-DCAQKATOSA-N Asn-Arg-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(O)=O MFFOYNGMOYFPBD-DCAQKATOSA-N 0.000 description 2
- KXEGPPNPXOKKHK-ZLUOBGJFSA-N Asn-Asp-Ala Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(O)=O KXEGPPNPXOKKHK-ZLUOBGJFSA-N 0.000 description 2
- YVXRYLVELQYAEQ-SRVKXCTJSA-N Asn-Leu-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(=O)N)N YVXRYLVELQYAEQ-SRVKXCTJSA-N 0.000 description 2
- CNKAZIGBGQIHLL-GUBZILKMSA-N Asp-Arg-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(=O)O)N CNKAZIGBGQIHLL-GUBZILKMSA-N 0.000 description 2
- VFUXXFVCYZPOQG-WDSKDSINSA-N Asp-Glu-Gly Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O VFUXXFVCYZPOQG-WDSKDSINSA-N 0.000 description 2
- YNCHFVRXEQFPBY-BQBZGAKWSA-N Asp-Gly-Arg Chemical compound OC(=O)C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCN=C(N)N YNCHFVRXEQFPBY-BQBZGAKWSA-N 0.000 description 2
- CYCKJEFVFNRWEZ-UGYAYLCHSA-N Asp-Ile-Asn Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(O)=O CYCKJEFVFNRWEZ-UGYAYLCHSA-N 0.000 description 2
- UZFHNLYQWMGUHU-DCAQKATOSA-N Asp-Lys-Arg Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O UZFHNLYQWMGUHU-DCAQKATOSA-N 0.000 description 2
- RXBGWGRSWXOBGK-KKUMJFAQSA-N Asp-Lys-Tyr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O RXBGWGRSWXOBGK-KKUMJFAQSA-N 0.000 description 2
- AHWRSSLYSGLBGD-CIUDSAMLSA-N Asp-Pro-Glu Chemical compound OC(=O)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O AHWRSSLYSGLBGD-CIUDSAMLSA-N 0.000 description 2
- GGRSYTUJHAZTFN-IHRRRGAJSA-N Asp-Pro-Tyr Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CC(=O)O)N)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)O GGRSYTUJHAZTFN-IHRRRGAJSA-N 0.000 description 2
- WAEDSQFVZJUHLI-BYULHYEWSA-N Asp-Val-Asp Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O WAEDSQFVZJUHLI-BYULHYEWSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- LZRMPXRYLLTAJX-GUBZILKMSA-N Gln-Arg-Glu Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(O)=O LZRMPXRYLLTAJX-GUBZILKMSA-N 0.000 description 2
- BTSPOOHJBYJRKO-CIUDSAMLSA-N Gln-Asp-Arg Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O BTSPOOHJBYJRKO-CIUDSAMLSA-N 0.000 description 2
- GHYJGDCPHMSFEJ-GUBZILKMSA-N Gln-Gln-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCC(=O)N)N GHYJGDCPHMSFEJ-GUBZILKMSA-N 0.000 description 2
- NXPXQIZKDOXIHH-JSGCOSHPSA-N Gln-Gly-Trp Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CCC(=O)N)N NXPXQIZKDOXIHH-JSGCOSHPSA-N 0.000 description 2
- CSMHMEATMDCQNY-DZKIICNBSA-N Gln-Val-Tyr Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O CSMHMEATMDCQNY-DZKIICNBSA-N 0.000 description 2
- WZZSKAJIHTUUSG-ACZMJKKPSA-N Glu-Ala-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCC(O)=O WZZSKAJIHTUUSG-ACZMJKKPSA-N 0.000 description 2
- JDUKCSSHWNIQQZ-IHRRRGAJSA-N Glu-Phe-Glu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O JDUKCSSHWNIQQZ-IHRRRGAJSA-N 0.000 description 2
- SYWCGQOIIARSIX-SRVKXCTJSA-N Glu-Pro-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(O)=O SYWCGQOIIARSIX-SRVKXCTJSA-N 0.000 description 2
- PHONXOACARQMPM-BQBZGAKWSA-N Gly-Ala-Met Chemical compound [H]NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(O)=O PHONXOACARQMPM-BQBZGAKWSA-N 0.000 description 2
- WKJKBELXHCTHIJ-WPRPVWTQSA-N Gly-Arg-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CCCN=C(N)N WKJKBELXHCTHIJ-WPRPVWTQSA-N 0.000 description 2
- SOEATRRYCIPEHA-BQBZGAKWSA-N Gly-Glu-Glu Chemical compound [H]NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O SOEATRRYCIPEHA-BQBZGAKWSA-N 0.000 description 2
- QSVCIFZPGLOZGH-WDSKDSINSA-N Gly-Glu-Ser Chemical compound NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O QSVCIFZPGLOZGH-WDSKDSINSA-N 0.000 description 2
- KMSGYZQRXPUKGI-BYPYZUCNSA-N Gly-Gly-Asn Chemical compound NCC(=O)NCC(=O)N[C@H](C(O)=O)CC(N)=O KMSGYZQRXPUKGI-BYPYZUCNSA-N 0.000 description 2
- SOEGEPHNZOISMT-BYPYZUCNSA-N Gly-Ser-Gly Chemical compound NCC(=O)N[C@@H](CO)C(=O)NCC(O)=O SOEGEPHNZOISMT-BYPYZUCNSA-N 0.000 description 2
- WNGHUXFWEWTKAO-YUMQZZPRSA-N Gly-Ser-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)CN WNGHUXFWEWTKAO-YUMQZZPRSA-N 0.000 description 2
- WCORRBXVISTKQL-WHFBIAKZSA-N Gly-Ser-Ser Chemical compound NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O WCORRBXVISTKQL-WHFBIAKZSA-N 0.000 description 2
- AFMOTCMSEBITOE-YEPSODPASA-N Gly-Val-Thr Chemical compound NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O AFMOTCMSEBITOE-YEPSODPASA-N 0.000 description 2
- JBCLFWXMTIKCCB-UHFFFAOYSA-N H-Gly-Phe-OH Natural products NCC(=O)NC(C(O)=O)CC1=CC=CC=C1 JBCLFWXMTIKCCB-UHFFFAOYSA-N 0.000 description 2
- SYMSVYVUSPSAAO-IHRRRGAJSA-N His-Arg-Leu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(O)=O SYMSVYVUSPSAAO-IHRRRGAJSA-N 0.000 description 2
- LMMPTUVWHCFTOT-GARJFASQSA-N His-Asp-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC2=CN=CN2)N)C(=O)O LMMPTUVWHCFTOT-GARJFASQSA-N 0.000 description 2
- VBOFRJNDIOPNDO-YUMQZZPRSA-N His-Gly-Asn Chemical compound C1=C(NC=N1)C[C@@H](C(=O)NCC(=O)N[C@@H](CC(=O)N)C(=O)O)N VBOFRJNDIOPNDO-YUMQZZPRSA-N 0.000 description 2
- QTMKFZAYZKBFRC-BZSNNMDCSA-N His-Tyr-His Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)NC(=O)[C@H](CC3=CN=CN3)N)O QTMKFZAYZKBFRC-BZSNNMDCSA-N 0.000 description 2
- ZGKVPOSSTGHJAF-HJPIBITLSA-N Ile-Tyr-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CO)C(=O)O)N ZGKVPOSSTGHJAF-HJPIBITLSA-N 0.000 description 2
- ZYVTXBXHIKGZMD-QSFUFRPTSA-N Ile-Val-Asn Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)O)N ZYVTXBXHIKGZMD-QSFUFRPTSA-N 0.000 description 2
- FADYJNXDPBKVCA-UHFFFAOYSA-N L-Phenylalanyl-L-lysin Natural products NCCCCC(C(O)=O)NC(=O)C(N)CC1=CC=CC=C1 FADYJNXDPBKVCA-UHFFFAOYSA-N 0.000 description 2
- SENJXOPIZNYLHU-UHFFFAOYSA-N L-leucyl-L-arginine Natural products CC(C)CC(N)C(=O)NC(C(O)=O)CCCN=C(N)N SENJXOPIZNYLHU-UHFFFAOYSA-N 0.000 description 2
- OXRLYTYUXAQTHP-YUMQZZPRSA-N Leu-Gly-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(O)=O OXRLYTYUXAQTHP-YUMQZZPRSA-N 0.000 description 2
- WXUOJXIGOPMDJM-SRVKXCTJSA-N Leu-Lys-Asn Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O WXUOJXIGOPMDJM-SRVKXCTJSA-N 0.000 description 2
- IRNSXVOWSXSULE-DCAQKATOSA-N Lys-Ala-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN IRNSXVOWSXSULE-DCAQKATOSA-N 0.000 description 2
- NQCJGQHHYZNUDK-DCAQKATOSA-N Lys-Arg-Ser Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CO)C(O)=O)CCCN=C(N)N NQCJGQHHYZNUDK-DCAQKATOSA-N 0.000 description 2
- QYOXSYXPHUHOJR-GUBZILKMSA-N Lys-Asn-Glu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O QYOXSYXPHUHOJR-GUBZILKMSA-N 0.000 description 2
- FLCMXEFCTLXBTL-DCAQKATOSA-N Lys-Asp-Arg Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N FLCMXEFCTLXBTL-DCAQKATOSA-N 0.000 description 2
- NRQRKMYZONPCTM-CIUDSAMLSA-N Lys-Asp-Ser Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O NRQRKMYZONPCTM-CIUDSAMLSA-N 0.000 description 2
- DCRWPTBMWMGADO-AVGNSLFASA-N Lys-Glu-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O DCRWPTBMWMGADO-AVGNSLFASA-N 0.000 description 2
- ZMMDPRTXLAEMOD-BZSNNMDCSA-N Lys-His-Phe Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O ZMMDPRTXLAEMOD-BZSNNMDCSA-N 0.000 description 2
- OEYKVQKYCHATHO-SZMVWBNQSA-N Lys-Trp-Gln Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CCCCN)N OEYKVQKYCHATHO-SZMVWBNQSA-N 0.000 description 2
- RQILLQOQXLZTCK-KBPBESRZSA-N Lys-Tyr-Gly Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)NCC(O)=O RQILLQOQXLZTCK-KBPBESRZSA-N 0.000 description 2
- RIPJMCFGQHGHNP-RHYQMDGZSA-N Lys-Val-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCCN)N)O RIPJMCFGQHGHNP-RHYQMDGZSA-N 0.000 description 2
- DRXODWRPPUFIAY-DCAQKATOSA-N Met-Asn-Lys Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(O)=O)CCCCN DRXODWRPPUFIAY-DCAQKATOSA-N 0.000 description 2
- CEGVMWAVGBRVFS-XGEHTFHBSA-N Met-Cys-Thr Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@@H](C)O)C(O)=O CEGVMWAVGBRVFS-XGEHTFHBSA-N 0.000 description 2
- NHXXGBXJTLRGJI-GUBZILKMSA-N Met-Pro-Ser Chemical compound [H]N[C@@H](CCSC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O NHXXGBXJTLRGJI-GUBZILKMSA-N 0.000 description 2
- ZDJICAUBMUKVEJ-CIUDSAMLSA-N Met-Ser-Gln Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCC(N)=O ZDJICAUBMUKVEJ-CIUDSAMLSA-N 0.000 description 2
- YBAFDPFAUTYYRW-UHFFFAOYSA-N N-L-alpha-glutamyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CCC(O)=O YBAFDPFAUTYYRW-UHFFFAOYSA-N 0.000 description 2
- KZNQNBZMBZJQJO-UHFFFAOYSA-N N-glycyl-L-proline Natural products NCC(=O)N1CCCC1C(O)=O KZNQNBZMBZJQJO-UHFFFAOYSA-N 0.000 description 2
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 2
- 108700026244 Open Reading Frames Proteins 0.000 description 2
- BJEYSVHMGIJORT-NHCYSSNCSA-N Phe-Ala-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=CC=C1 BJEYSVHMGIJORT-NHCYSSNCSA-N 0.000 description 2
- LBSARGIQACMGDF-WBAXXEDZSA-N Phe-Ala-Phe Chemical compound C([C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 LBSARGIQACMGDF-WBAXXEDZSA-N 0.000 description 2
- CUMXHKAOHNWRFQ-BZSNNMDCSA-N Phe-Asp-Tyr Chemical compound C([C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=CC=C1 CUMXHKAOHNWRFQ-BZSNNMDCSA-N 0.000 description 2
- KOUUGTKGEQZRHV-KKUMJFAQSA-N Phe-Gln-Arg Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O KOUUGTKGEQZRHV-KKUMJFAQSA-N 0.000 description 2
- GOUWCZRDTWTODO-YDHLFZDLSA-N Phe-Val-Asn Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O GOUWCZRDTWTODO-YDHLFZDLSA-N 0.000 description 2
- HOTVCUAVDQHUDB-UFYCRDLUSA-N Pro-Phe-Tyr Chemical compound C([C@@H](C(=O)O)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H]1NCCC1)C1=CC=C(O)C=C1 HOTVCUAVDQHUDB-UFYCRDLUSA-N 0.000 description 2
- KDBHVPXBQADZKY-GUBZILKMSA-N Pro-Pro-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 KDBHVPXBQADZKY-GUBZILKMSA-N 0.000 description 2
- 108010079005 RDV peptide Proteins 0.000 description 2
- BTKUIVBNGBFTTP-WHFBIAKZSA-N Ser-Ala-Gly Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)NCC(O)=O BTKUIVBNGBFTTP-WHFBIAKZSA-N 0.000 description 2
- HRNQLKCLPVKZNE-CIUDSAMLSA-N Ser-Ala-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O HRNQLKCLPVKZNE-CIUDSAMLSA-N 0.000 description 2
- BRKHVZNDAOMAHX-BIIVOSGPSA-N Ser-Ala-Pro Chemical compound C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CO)N BRKHVZNDAOMAHX-BIIVOSGPSA-N 0.000 description 2
- QEDMOZUJTGEIBF-FXQIFTODSA-N Ser-Arg-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(O)=O QEDMOZUJTGEIBF-FXQIFTODSA-N 0.000 description 2
- FTVRVZNYIYWJGB-ACZMJKKPSA-N Ser-Asp-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O FTVRVZNYIYWJGB-ACZMJKKPSA-N 0.000 description 2
- BNFVPSRLHHPQKS-WHFBIAKZSA-N Ser-Asp-Gly Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O BNFVPSRLHHPQKS-WHFBIAKZSA-N 0.000 description 2
- SNVIOQXAHVORQM-WDSKDSINSA-N Ser-Gly-Gln Chemical compound [H]N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(O)=O SNVIOQXAHVORQM-WDSKDSINSA-N 0.000 description 2
- MIJWOJAXARLEHA-WDSKDSINSA-N Ser-Gly-Glu Chemical compound OC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCC(O)=O MIJWOJAXARLEHA-WDSKDSINSA-N 0.000 description 2
- SFTZWNJFZYOLBD-ZDLURKLDSA-N Ser-Gly-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CO SFTZWNJFZYOLBD-ZDLURKLDSA-N 0.000 description 2
- QBUWQRKEHJXTOP-DCAQKATOSA-N Ser-His-Arg Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O QBUWQRKEHJXTOP-DCAQKATOSA-N 0.000 description 2
- OCWWJBZQXGYQCA-DCAQKATOSA-N Ser-Lys-Met Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(O)=O OCWWJBZQXGYQCA-DCAQKATOSA-N 0.000 description 2
- WGDYNRCOQRERLZ-KKUMJFAQSA-N Ser-Lys-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)N WGDYNRCOQRERLZ-KKUMJFAQSA-N 0.000 description 2
- AXKJPUBALUNJEO-UBHSHLNASA-N Ser-Trp-Asn Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(N)=O)C(O)=O AXKJPUBALUNJEO-UBHSHLNASA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 238000002105 Southern blotting Methods 0.000 description 2
- NJEMRSFGDNECGF-GCJQMDKQSA-N Thr-Ala-Asp Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC(O)=O NJEMRSFGDNECGF-GCJQMDKQSA-N 0.000 description 2
- BSNZTJXVDOINSR-JXUBOQSCSA-N Thr-Ala-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O BSNZTJXVDOINSR-JXUBOQSCSA-N 0.000 description 2
- CAGTXGDOIFXLPC-KZVJFYERSA-N Thr-Arg-Ala Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](C)C(O)=O)CCCN=C(N)N CAGTXGDOIFXLPC-KZVJFYERSA-N 0.000 description 2
- UDQBCBUXAQIZAK-GLLZPBPUSA-N Thr-Glu-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O UDQBCBUXAQIZAK-GLLZPBPUSA-N 0.000 description 2
- QQWNRERCGGZOKG-WEDXCCLWSA-N Thr-Gly-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(O)=O QQWNRERCGGZOKG-WEDXCCLWSA-N 0.000 description 2
- KZSYAEWQMJEGRZ-RHYQMDGZSA-N Thr-Leu-Val Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O KZSYAEWQMJEGRZ-RHYQMDGZSA-N 0.000 description 2
- VUXIQSUQQYNLJP-XAVMHZPKSA-N Thr-Ser-Pro Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CO)C(=O)N1CCC[C@@H]1C(=O)O)N)O VUXIQSUQQYNLJP-XAVMHZPKSA-N 0.000 description 2
- BTAJAOWZCWOHBU-HSHDSVGOSA-N Thr-Val-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)[C@@H](C)O)C(C)C)C(O)=O)=CNC2=C1 BTAJAOWZCWOHBU-HSHDSVGOSA-N 0.000 description 2
- RWAYYYOZMHMEGD-XIRDDKMYSA-N Trp-Leu-Ser Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O)=CNC2=C1 RWAYYYOZMHMEGD-XIRDDKMYSA-N 0.000 description 2
- ACGIVBXINJFALS-HKUYNNGSSA-N Trp-Phe-Gly Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)N ACGIVBXINJFALS-HKUYNNGSSA-N 0.000 description 2
- UJGDFQRPYGJBEH-AAEUAGOBSA-N Trp-Ser-Gly Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CO)C(=O)NCC(=O)O)N UJGDFQRPYGJBEH-AAEUAGOBSA-N 0.000 description 2
- XKTWZYNTLXITCY-QRTARXTBSA-N Trp-Val-Asn Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O)=CNC2=C1 XKTWZYNTLXITCY-QRTARXTBSA-N 0.000 description 2
- IELISNUVHBKYBX-XDTLVQLUSA-N Tyr-Ala-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 IELISNUVHBKYBX-XDTLVQLUSA-N 0.000 description 2
- PMDWYLVWHRTJIW-STQMWFEESA-N Tyr-Gly-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CC1=CC=C(O)C=C1 PMDWYLVWHRTJIW-STQMWFEESA-N 0.000 description 2
- LTSIAOZUVISRAQ-QWRGUYRKSA-N Tyr-Gly-Cys Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)NCC(=O)N[C@@H](CS)C(=O)O)N)O LTSIAOZUVISRAQ-QWRGUYRKSA-N 0.000 description 2
- PJWCWGXAVIVXQC-STECZYCISA-N Tyr-Ile-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 PJWCWGXAVIVXQC-STECZYCISA-N 0.000 description 2
- BSCBBPKDVOZICB-KKUMJFAQSA-N Tyr-Leu-Asp Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O BSCBBPKDVOZICB-KKUMJFAQSA-N 0.000 description 2
- XGZBEGGGAUQBMB-KJEVXHAQSA-N Tyr-Pro-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC2=CC=C(C=C2)O)N)O XGZBEGGGAUQBMB-KJEVXHAQSA-N 0.000 description 2
- GQVZBMROTPEPIF-SRVKXCTJSA-N Tyr-Ser-Asp Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O GQVZBMROTPEPIF-SRVKXCTJSA-N 0.000 description 2
- ZSZFTYVFQLUWBF-QXEWZRGKSA-N Val-Asp-Met Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCSC)C(=O)O)N ZSZFTYVFQLUWBF-QXEWZRGKSA-N 0.000 description 2
- BGXVHVMJZCSOCA-AVGNSLFASA-N Val-Pro-Lys Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)O)N BGXVHVMJZCSOCA-AVGNSLFASA-N 0.000 description 2
- PDDJTOSAVNRJRH-UNQGMJICSA-N Val-Thr-Phe Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H](C(C)C)N)O PDDJTOSAVNRJRH-UNQGMJICSA-N 0.000 description 2
- PFMSJVIPEZMKSC-DZKIICNBSA-N Val-Tyr-Glu Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N PFMSJVIPEZMKSC-DZKIICNBSA-N 0.000 description 2
- 108010005233 alanylglutamic acid Proteins 0.000 description 2
- 108010040443 aspartyl-aspartic acid Proteins 0.000 description 2
- 108010069205 aspartyl-phenylalanine Proteins 0.000 description 2
- 108010092854 aspartyllysine Proteins 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 238000012217 deletion Methods 0.000 description 2
- 230000037430 deletion Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 108010080575 glutamyl-aspartyl-alanine Proteins 0.000 description 2
- 108010049041 glutamylalanine Proteins 0.000 description 2
- XBGGUPMXALFZOT-UHFFFAOYSA-N glycyl-L-tyrosine hemihydrate Natural products NCC(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 XBGGUPMXALFZOT-UHFFFAOYSA-N 0.000 description 2
- 108010089804 glycyl-threonine Proteins 0.000 description 2
- 108010010147 glycylglutamine Proteins 0.000 description 2
- 108010050848 glycylleucine Proteins 0.000 description 2
- 108010040030 histidinoalanine Proteins 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 108010000761 leucylarginine Proteins 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000002751 oligonucleotide probe Substances 0.000 description 2
- 108010018625 phenylalanylarginine Proteins 0.000 description 2
- 108010093296 prolyl-prolyl-alanine Proteins 0.000 description 2
- 230000010076 replication Effects 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 108010026333 seryl-proline Proteins 0.000 description 2
- 108700004896 tripeptide FEG Proteins 0.000 description 2
- 108010084932 tryptophyl-proline Proteins 0.000 description 2
- 108010051110 tyrosyl-lysine Proteins 0.000 description 2
- 108010027345 wheylin-1 peptide Proteins 0.000 description 2
- 125000000981 3-amino-3-oxopropyl group Chemical group [H]C([*])([H])C([H])([H])C(=O)N([H])[H] 0.000 description 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- 125000004042 4-aminobutyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])N([H])[H] 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 108010027529 Bio-glue Proteins 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- 239000003155 DNA primer Substances 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000620209 Escherichia coli DH5[alpha] Species 0.000 description 1
- 238000000636 Northern blotting Methods 0.000 description 1
- 108010038807 Oligopeptides Proteins 0.000 description 1
- 102000015636 Oligopeptides Human genes 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 241000520730 Streptomyces cinnamoneus Species 0.000 description 1
- 241000499056 Streptomyces griseocarneus Species 0.000 description 1
- 241000187389 Streptomyces lavendulae Species 0.000 description 1
- 241000218483 Streptomyces lydicus Species 0.000 description 1
- 241000187180 Streptomyces sp. Species 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 101150110946 gatC gene Proteins 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 235000020993 ground meat Nutrition 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 238000007857 nested PCR Methods 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000001542 size-exclusion chromatography Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
- 229940038773 trisodium citrate Drugs 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Landscapes
- Enzymes And Modification Thereof (AREA)
Abstract
Description
技术领域technical field
本发明涉及一种编码转谷氨酰胺酶的新DNA分子及其编码的转谷氨酰胺酶。The present invention relates to a novel DNA molecule encoding transglutaminase and the encoded transglutaminase.
背景技术Background technique
转谷氨酰胺酶是Ca2+依赖性酶,其催化蛋白质中谷氨酰胺侧链γ-氨甲酰基与赖氨酸侧链ε-氨基之间形成异肽键(isopeptidebond)。转谷氨酰胺酶可用于食品加工,如生产胶凝状交联凝胶,诱导纤维束表面交联以及生产干酪制品。转谷氨酰胺酶也可用于治疗慢性伤口症状以及作为生物胶。Transglutaminase is a Ca 2+ -dependent enzyme that catalyzes the formation of an isopeptide bond (isopeptide bond) between the glutamine side chain γ-carbamoyl group and the lysine side chain ε-amino group in proteins. Transglutaminase can be used in food processing, such as producing gelatinous cross-linked gels, inducing surface cross-linking of fiber bundles and producing cheese products. Transglutaminase is also useful in the treatment of chronic wound conditions and as a bioglue.
转谷氨酰胺酶在细胞外和细胞内均有发现。从许多动物和一些植物物种中已鉴别和鉴定了多种转谷氨酰胺酶。不幸的是,衍生自动物如豚鼠的转谷氨酰胺酶在产业上无法应用,因为难于以低成本获得大量的这种动物来源的转谷氨酰胺酶。目前仅揭示了很少几种微生物转谷氨酰胺酶,即来自菌种茂原链轮丝菌(Streptoverticilliummobaraense)、肉桂链轮丝菌(Streptoverticillium cinnamoneum)和灰肉色链轮丝菌(Streptoverticillium griseocarneum)(见美国专利5,156,956)以及来自预期为淡紫灰链霉菌(Streptomyces lavendulae)的菌种(见美国专利5,252,469)的转谷氨酰胺酶。根据Wu等,在所筛选的菌株中,拉达卡链轮丝菌(Streptoverticillium ladakanum)的转谷氨酰胺酶具有最高的活性(Wu等,1996,Chinese Agric.Chem.Soc.34(2):228-40)。Transglutaminase is found both extracellularly and intracellularly. A variety of transglutaminases have been identified and characterized from many animal and some plant species. Unfortunately, transglutaminases derived from animals such as guinea pigs are not available industrially because of the difficulty in obtaining such animal-derived transglutaminases at low cost in large quantities. Only a few microbial transglutaminases have been disclosed so far, namely from the species Streptoverticillium mobaraense, Streptoverticillium cinnamoneum and Streptoverticillium griseocarneum (see US Patent 5,156,956) and transglutaminase from a species predicted to be Streptomyces lavendulae (see US Patent 5,252,469). According to Wu et al., among the strains screened, the transglutaminase of Streptoverticillium ladakanum has the highest activity (Wu et al., 1996, Chinese Agric.Chem.Soc.34 (2): 228-40).
编码转谷氨酰胺酶的基因已从链轮丝菌菌种S-8112(Washizu等,1994,Biosci.Biotechnol.Biochem.58(1):82-7),肉桂链轮丝菌(Pasternack等,1998,Eur.J.Biochem.257(3):570-6),利迪链霉菌(Streptomyces lydicus)(WO9606931)和枯草芽孢杆菌(Kobayashi等,1998,J.Gen.Appl.Microbiol.44:85-91)中克隆。The gene encoding transglutaminase has been obtained from Streptothrix spp. S-8112 (Washizu et al., 1994, Biosci.Biotechnol.Biochem.58 (1): 82-7), Streptothrix cinnamomi (Pasternack et al., 1998, Eur.J.Biochem.257(3):570-6), Streptomyces lydicus (WO9606931) and Bacillus subtilis (Kobayashi et al., 1998, J.Gen.Appl.Microbiol.44:85 -91) cloned.
另外,目前基因工程技术已使得获得大量酶相对容易,这可通过分离编码酶的基因,确定酶基因的碱基序列,产生含有编码酶的基因的重组DNA,将重组DNA掺入微生物或动物或植物细胞,以及培养所获得的转化子而实现。In addition, the current genetic engineering technology has made it relatively easy to obtain a large number of enzymes, which can be achieved by isolating the gene encoding the enzyme, determining the base sequence of the enzyme gene, producing a recombinant DNA containing the gene encoding the enzyme, and incorporating the recombinant DNA into microorganisms or animals or plant cells, and culturing the obtained transformants.
发明内容Contents of the invention
本发明的一个目的是提供分离和纯化的DNA分子,其包含编码转谷氨酰胺酶的序列,其中所述核酸在高度严格条件下与SEQ IDNO:1所示序列或其互补序列杂交。An object of the present invention is to provide isolated and purified DNA molecules comprising a sequence encoding transglutaminase, wherein said nucleic acid hybridizes to the sequence shown in SEQ ID NO: 1 or its complementary sequence under highly stringent conditions.
本发明的另一目的是提供包含本发明的DNA分子的表达载体。Another object of the present invention is to provide expression vectors comprising the DNA molecules of the present invention.
本发明的再一目的是提供包含本发明的表达载体的宿主细胞。Another object of the present invention is to provide a host cell comprising the expression vector of the present invention.
本发明的又一目的是提供包含由本发明的DNA分子编码的氨基酸序列的多肽。Yet another object of the present invention is to provide a polypeptide comprising the amino acid sequence encoded by the DNA molecule of the present invention.
附图说明Description of drawings
图1示出茂原链轮丝菌CCRC 12165的转谷氨酰胺酶基因的部分片段(644bp)。Figure 1 shows a partial fragment (644bp) of the transglutaminase gene of Streptothrix mobara CCRC 12165.
图2示出KprI片段的3241个核苷酸序列以及位于KpnI片段的第二个开放读框的第700-1900位核苷酸附近的基因。Figure 2 shows the 3241 nucleotide sequence of the KprI fragment and the genes located around nucleotides 700-1900 of the second open reading frame of the KpnI fragment.
图3示出质粒pAE051和pAE052的限制图谱。Figure 3 shows restriction maps of plasmids pAE051 and pAE052.
图4示出质粒pAE051在浅青紫链霉菌(S.lividans)JT46中的表达活性。Figure 4 shows the expression activity of plasmid pAE051 in Streptomyces lividans (S. lividans) JT46.
具体实施方式Detailed ways
本发明特征在于编码得自拉达卡链轮丝菌(Streptoverticilliumladakanum)的转谷氨酰胺酶的新DNA分子。另外,本发明提供了表达所编码的具有高活性的转谷氨酰胺酶的构建体。The invention features a novel DNA molecule encoding a transglutaminase from Streptoverticillium ladakanum. In addition, the present invention provides a construct expressing the encoded transglutaminase with high activity.
定义definition
本文所用术语“分离的和纯化的”是指DNA分子或蛋白质从其天然细胞环境中,以及与细菌基因组的其它编码区的结合中经体外分离,从而其可被测序、复制和/或表达。优选地,本发明的分离的和纯化的DNA分子包含一个单编码区。虽然DNA分子包含一个单编码区,但是其可含有不会负面影响其功能的额外核苷酸。例如,5′和3′非编码区可含有不同数目的核苷酸。优选地,额外核苷酸位于单编码区之外。The term "isolated and purified" as used herein refers to the in vitro separation of a DNA molecule or protein from its natural cellular environment and association with other coding regions of the bacterial genome so that it can be sequenced, replicated and/or expressed. Preferably, the isolated and purified DNA molecules of the invention comprise a single coding region. Although a DNA molecule contains a single coding region, it may contain additional nucleotides that do not negatively affect its function. For example, the 5' and 3' noncoding regions may contain different numbers of nucleotides. Preferably, the additional nucleotides are located outside the single coding region.
本文所用术语“氨基酸序列”是指天然存在的蛋白质分子的氨基酸序列,“氨基酸序列”及类似术语如“多肽”或“蛋白质”并非将氨基酸序列限制为与所引述的蛋白质分子相关的完整氨基酸序列。氨基酸序列包括寡肽、肽、多肽或蛋白质序列,及其片段或部分,以及天然存在或合成的分子。The term "amino acid sequence" as used herein refers to the amino acid sequence of a naturally occurring protein molecule, and "amino acid sequence" and similar terms such as "polypeptide" or "protein" do not limit the amino acid sequence to the complete amino acid sequence associated with the referenced protein molecule . Amino acid sequences include oligopeptide, peptide, polypeptide or protein sequences, and fragments or portions thereof, as well as naturally occurring or synthetic molecules.
本文所用术语“缺失”是指氨基酸或核苷酸的变化,其中一或多个氨基酸或核苷酸残基被缺失。The term "deletion" as used herein refers to an amino acid or nucleotide change wherein one or more amino acid or nucleotide residues are deleted.
本文所用术语“插入”或“添加”是指导致与天然存在的分子相比添加一或多个氨基酸或核苷酸残基的氨基酸或核苷酸序列的变化。The term "insertion" or "addition" as used herein refers to a change in amino acid or nucleotide sequence that results in the addition of one or more amino acid or nucleotide residues compared to a naturally occurring molecule.
本文所用术语“载体”是指能转运与其连接的另一核酸的核酸分子。一种优选的载体是附加体,即能在染色体外复制的核酸。优选的载体是能够自动复制和/或表达与其相连的核酸的载体。能指导与其可操纵连接的基因的表达的载体在本文中称作“表达载体”。通常,重组DNA技术中实用的表达载体通常是“质粒”形式,其通常是指环状双链DNA环,其在载体形式中不与染色体结合。The term "vector" as used herein refers to a nucleic acid molecule capable of transporting another nucleic acid to which it has been linked. A preferred vector is an episome, ie a nucleic acid capable of extrachromosomal replication. Preferred vectors are those capable of autonomous replication and/or expression of nucleic acids to which they are linked. A vector capable of directing the expression of a gene to which it is operably linked is referred to herein as an "expression vector." In general, expression vectors of practical use in recombinant DNA techniques are usually in the form of "plasmids", which generally refer to circular double-stranded DNA loops which, in vector form, are not chromosomally bound.
本文所用术语“宿主细胞”是指可被载体如质粒感染的宿主的细胞。适于本发明的宿主包括本领域通常和常规使用的宿主。The term "host cell" as used herein refers to a cell of a host that can be infected by a vector such as a plasmid. Hosts suitable for the present invention include hosts commonly and routinely used in the art.
核酸nucleic acid
本发明的一个目的是提供分离的和纯化的DNA分子,其包含编码转谷氨酰胺酶的序列,其中所述核酸在高度严格条件下与SEQ IDNO:1所示序列或其互补序列杂交。更优选地,所述DNA分子编码具有SEQ ID NO:2所示氨基酸序列的转谷氨酰胺酶。最优选地,所示DNA分子由SEQ ID NO:1所示的完整核苷酸序列代表。An object of the present invention is to provide isolated and purified DNA molecules comprising a sequence encoding transglutaminase, wherein said nucleic acid hybridizes to the sequence shown in SEQ ID NO: 1 or its complementary sequence under highly stringent conditions. More preferably, said DNA molecule encoding has the transglutaminase of aminoacid sequence shown in SEQ ID NO:2. Most preferably, the DNA molecule shown is represented by the complete nucleotide sequence shown in SEQ ID NO:1.
具有序列相似性的核酸由在高度严格条件下的杂交而检测。高度严格杂交条件是指在例如含有0.25M Na2HPO4(pH7.4),7%十二烷基磺酸钠(SDS),1%牛血清白蛋白(BSA),1.0mM乙二胺四乙酸(EDTA,pH8)的缓冲液中于65℃杂交,随后用0.1%SDS和0.1倍SSC在65℃洗3次(0.1倍SSC含有0.015M氯化钠和0.0015M柠檬酸三钠,pH7.0)。Nucleic acids with sequence similarity are detected by hybridization under highly stringent conditions. Highly stringent hybridization conditions refer to, for example, containing 0.25M Na 2 HPO 4 (pH 7.4), 7% sodium dodecyl sulfate (SDS), 1% bovine serum albumin (BSA), 1.0 mM ethylenediaminetetra Hybridization was carried out at 65°C in acetic acid (EDTA, pH8) buffer, followed by washing three times at 65°C with 0.1% SDS and 0.1 times SSC (0.1 times SSC contained 0.015M sodium chloride and 0.0015M trisodium citrate, pH7. 0).
编码本发明的转谷氨酰胺酶的序列可以本领域已知的各种方式突变以产生在启动子强度、编码的蛋白质的序列等方面的定向变化。这种突变的DNA序列或产物与本文提供的序列基本相似,即它们将有至少一个核苷酸或氨基酸的不同,并可有至少两个但不超过约十个核苷酸或氨基酸的不同。所述变化可以是取代、插入或缺失。The sequence encoding the transglutaminase of the present invention can be mutated in various ways known in the art to produce directional changes in promoter strength, sequence of the encoded protein, and the like. Such mutated DNA sequences or products are substantially similar to the sequences provided herein, ie, they will differ by at least one nucleotide or amino acid, and may differ by at least two, but not more than about ten nucleotides or amino acids. The changes may be substitutions, insertions or deletions.
目前有若干不同的方法来分离本发明的DNA。这些方法包括,例如,纯化酶蛋白,随后将其直接进行氨基酸微测序或在限制裂解后进行氨基酸微测序。所获得的部分氨基酸序列可用于设计简并寡核苷酸探针或引物以用于经聚合酶链反应(PCR)产生独有的非简并核苷酸序列,即可随后用作探针筛选DNA文库的序列。也可使用抗纯化的蛋白质的抗体从DNA表达文库中分离DNA克隆。或者,可使用相关酶的DNA分子的序列作为克隆策略的起点。这一方法通常称为“同源性克隆”。使用来自不同物种的序列信息的另一种方式是在来自不同物种的相关DNA分子中缩小高序列同源性的区域,并进行聚合酶链反应测序扩增方法(PCR)以获得“物种特异性”非简并核苷酸序列。这种序列随后可用于DNA文库筛选或甚至用于直接基于PCR的DNA克隆。There are currently several different methods for isolating the DNA of the invention. These methods include, for example, purification of enzyme proteins followed by amino acid microsequencing directly or after restriction cleavage. The obtained partial amino acid sequences can be used to design degenerate oligonucleotide probes or primers for generating unique non-degenerate nucleotide sequences via polymerase chain reaction (PCR), which can then be used for probe screening Sequence of the DNA library. DNA clones can also be isolated from DNA expression libraries using antibodies raised against purified proteins. Alternatively, the sequence of the DNA molecule of the relevant enzyme can be used as a starting point for a cloning strategy. This method is often referred to as "homologous cloning". Another way of using sequence information from different species is to narrow down regions of high sequence homology in related DNA molecules from different species and perform the polymerase chain reaction sequencing amplification method (PCR) to obtain "species-specific "Non-degenerate nucleotide sequence. This sequence can then be used for DNA library screening or even for direct PCR-based DNA cloning.
使用本领域熟知的生物化学程序,可用寡核苷酸探针在各种样品中检测和扩增本发明的DNA分子。例如,可使用应用标记探针的Southern或Northern印迹杂交技术。或者,可使用PCR技术,并且扩增的PCR产物的核酸测序可用于检测DNA中的突变。Oligonucleotide probes can be used to detect and amplify the DNA molecules of the invention in a variety of samples using biochemical procedures well known in the art. For example, Southern or Northern blot hybridization techniques using labeled probes can be used. Alternatively, PCR technology can be used, and nucleic acid sequencing of the amplified PCR products can be used to detect mutations in the DNA.
表达载体和宿主系统Expression Vectors and Host Systems
本发明的另一目的是提供含有SEQ ID NO:1所示DNA分子的表达载体。为了表达生物活性的转谷氨酰胺酶,编码转谷氨酰胺酶的核酸序列可被插入合适的表达载体即含有转录和翻译所插入的编码序列所必需的元件的载体中。根据本发明,可使用本领域熟知的方法构建含有图1所示DNA分子以及合适的转录和翻译控制元件的表达载体。这些方法包括体外重组DNA技术,合成技术和体内基因重组。Another object of the present invention is to provide an expression vector containing the DNA molecule shown in SEQ ID NO:1. In order to express the biologically active transglutaminase, the nucleic acid sequence encoding the transglutaminase can be inserted into a suitable expression vector, that is, a vector containing elements necessary for transcription and translation of the inserted coding sequence. According to the present invention, methods well known in the art can be used to construct expression vectors containing the DNA molecule shown in Figure 1 and appropriate transcriptional and translational control elements. These methods include in vitro recombinant DNA techniques, synthetic techniques and in vivo genetic recombination.
本发明的另一目的是提供含有表达载体的宿主细胞,所述表达载体含有SEQ ID NO:1所示的DNA分子。根据本发明,可使用各种宿主系统以含有和表达编码转谷氨酰胺酶的序列,这些宿主系统包括但不限于用重组噬菌体、质粒或粘粒DNA表达载体转化的微生物,如细菌;用酵母表达载体转化的载体;用病毒表达载体或细菌表达载体转化的植物细胞系统;或者动物细胞系统。优选地,用载体转化浅青紫链霉菌(Streptomyces lividans)以表达转谷氨酰胺酶。Another object of the present invention is to provide a host cell containing an expression vector containing the DNA molecule shown in SEQ ID NO: 1. According to the present invention, various host systems can be used to contain and express the sequence encoding transglutaminase, and these host systems include but are not limited to microorganisms transformed with recombinant phage, plasmid or cosmid DNA expression vectors, such as bacteria; A vector transformed with an expression vector; a plant cell system transformed with a viral expression vector or a bacterial expression vector; or an animal cell system. Preferably, Streptomyces lividans is transformed with the vector to express transglutaminase.
多肽polypeptide
本发明的另一目的是提供一种多肽,其包含由SEQ ID NO:1所示的DNA分子编码的氨基酸序列。优选地,所述多肽包含SEQ IDNO:2所示的氨基酸序列。Another object of the present invention is to provide a polypeptide comprising the amino acid sequence encoded by the DNA molecule shown in SEQ ID NO:1. Preferably, the polypeptide comprises the amino acid sequence shown in SEQ ID NO: 2.
本发明的多肽可以大量提供。通过采用表达宿主,可根据常规方式分离和纯化蛋白质。可制备表达宿主的裂解物,并用HPLC、排阻层析、凝胶电泳、亲和层析或其它纯化技术纯化裂解物。纯化的蛋白质的纯度通常至少为80%,优选至少90%,并可达100%。纯化是指无其它蛋白质和细胞碎片。The polypeptides of the invention can be provided in large quantities. By using an expression host, proteins can be isolated and purified according to conventional methods. Lysates of expression hosts can be prepared and purified using HPLC, size exclusion chromatography, gel electrophoresis, affinity chromatography, or other purification techniques. Purified proteins are generally at least 80%, preferably at least 90%, and up to 100% pure. Purified means free from other proteins and cellular debris.
用途use
本发明的DNA分子可用于编码转谷氨酰胺酶。大量表达DNA分子以大量生产转谷氨酰胺酶。得到的转谷氨酰胺酶具有各种工业用途,包括胶凝蛋白质,改善面粉的烘烤品质,从蛋白质、脂肪和水生产糊状食品或食品成分,从浓缩乳中生产干酪,粘合碎肉或鱼制品,改善食品蛋白的口味和组织,在皮革加工中固定酪蛋白,擦鞋等。The DNA molecules of the present invention can be used to encode transglutaminases. The DNA molecule is expressed in large quantities to produce a large amount of transglutaminase. The resulting transglutaminase has various industrial uses including gelling proteins, improving the baking quality of flour, producing pasty food or food ingredients from protein, fat and water, producing cheese from concentrated milk, binding ground meat Or fish products, improve the taste and texture of food protein, fix casein in leather processing, shine shoes, etc.
下述实施例是举例性而非限制性。The following examples are illustrative and not limiting.
实施例1拉达卡链轮丝菌的转谷氨酰胺酶基因The transglutaminase gene of embodiment 1 Ladaka sp.
A.拉达卡链轮丝菌的转谷氨酰胺酶基因的克隆A. Cloning of the transglutaminase gene of Streptomyces ladaka
(1)PCR扩增和纯化拉达卡链轮丝菌的转谷氨酰胺酶基因片段根据两个氨基酸片段FDEEKGF和KVKQGWP设计简并引物,这两个氨基酸片段是由Washizu等在1994年克隆的链轮丝菌菌种S-8112的转谷氨酰胺酶氨基酸序列(Washizu K.等,Biosci.Biotechnol.Biochem.58(1):82-7)中简并性最低的区域。两个简并引物为:(1) PCR amplification and purification of the transglutaminase gene fragment of Streptomyces ladaka, degenerate primers were designed according to two amino acid fragments FDEEKGF and KVKQGWP, which were cloned by Washizu et al. in 1994 The least degenerate region in the transglutaminase amino acid sequence of Streptomyces sp. S-8112 (Washizu K. et al., Biosci. Biotechnol. Biochem. 58(1):82-7). The two degenerate primers are:
5’-aaaaacctgaaaccctt(ct)ga(ct)ga(ag)ga(ag)aa(ag)gg(gact)tt-3’,和5'-aaaaacctgaaaccctt(ct)ga(ct)ga(ag)ga(ag)aa(ag)gg(gact)tt-3', and
5’-cttatcaacggatacggcca(gatc)cc(tc)tg(tc)tt(gact)ac(tc)tt-3’。5'-cttatcaacggatacggcca(gatc)cc(tc)tg(tc)tt(gact)ac(tc)tt-3'.
两个巢式引物为:The two nested primers are:
5’-aaaaacctgaaaccc-3’,和5'-aaaaacctgaaaccc-3', and
5’cttatcaacggatac-3’。5'cttatcaacggatac-3'.
通过巢式PCR扩增茂原链轮丝菌CCRC 12165的转谷氨酰胺酶的部分片段,结果显示约650bp的一条DNA带,其相应于PCR产物的计算长度(644bp)。所得DNA序列示于图1(SEQ ID NO:3)。茂原链轮丝菌CCRC12165见台湾新竹食品工业发展研究所(FIRDI)培养物寄存和研究中心的目录。A partial fragment of the transglutaminase of Streptomyces mobara CCRC 12165 was amplified by nested PCR, and the result showed a DNA band of about 650bp, which corresponded to the calculated length of the PCR product (644bp). The resulting DNA sequence is shown in Figure 1 (SEQ ID NO: 3). For S. mobara CCRC12165, see the catalog of the Culture Deposit and Research Center of the Food Industry Development Institute (FIRDI), Hsinchu, Taiwan.
(2)用茂原链轮丝菌的部分转谷氨酰胺酶基因片段作为探针探查拉达卡链轮丝菌的完整转谷氨酰胺酶基因(2) Using the partial transglutaminase gene fragment of Streptotrichum mobara as a probe to detect the complete transglutaminase gene of Streptotrichum ladaka
用上述644bp DNA作为探针进行Southern印迹实验。在拉达卡链轮丝菌基因组的下列限制酶切片段中检测到信号:8.4kb BamHIDNA,6kb BclI DNA,9kb NcoI DNA和7.5kb PstI DNA。拉达卡链轮丝菌见台湾新竹食品工业发展研究所(FIRDI)培养物寄存和研究中心的目录(登录号CCRC12422)。Southern blot experiments were performed using the above 644bp DNA as a probe. Signals were detected in the following restriction fragments of the S. ladaka genome: 8.4 kb BamHI DNA, 6 kb BclI DNA, 9 kb NcoI DNA and 7.5 kb PstI DNA. For S. ladaka, see the catalog of the Culture Depository and Research Center of the Food Industry Development Institute (FIRDI), Hsinchu, Taiwan (Accession No. CCRC12422).
为了纯化所述包含转谷氨酰胺酶基因的DNA片段,将拉达卡链轮丝菌基因组DNA用NcoI酶切并进行电泳分离。将纯化的9kbDNA插入用NcoI酶切的pMTL23载体中并转化大肠杆菌DH5α而形成DNA文库。再次使用上述644bp DNA作为探针进行菌落杂交实验,并选择包含拉达卡链轮丝菌的转谷氨酰胺酶基因的重组载体。由于所述NcoI片段太大而不能测序,克隆一包含转谷氨酰胺酶基因的3.2kb KpnI片段并插入pMT23载体上的KpnI酶切位点(形成pAE021),随后进行测序。KpnI片段的3241个核苷酸序列示于图2。用GCG提供的密码优选软件分析所述序列,预计基因位于KpnI片段序列的约700-1900位核苷酸处(图2)。所述基因是拉达卡链轮丝菌的转谷氨酰胺酶基因。从上述核苷酸序列推导的氨基酸序列也示于图2,其由410个氨基酸组成,其分子量为45780.2道尔顿。预计拉达卡链轮丝菌的成熟转谷氨酰胺酶起自第80位氨基酸并由331个氨基酸组成(图2的下划线区),其分子量为37922.3道尔顿,等电点为7.07。In order to purify the DNA fragment containing the transglutaminase gene, the genomic DNA of Streptomyces ladaka was digested with NcoI and separated by electrophoresis. The purified 9kb DNA was inserted into the pMTL23 vector digested with NcoI and transformed into Escherichia coli DH5α to form a DNA library. Use above-mentioned 644bp DNA again as probe to carry out bacterium colony hybridization experiment, and select the recombinant vector that comprises the transglutaminase gene of S. ladaka. Since the NcoI fragment was too large to be sequenced, a 3.2 kb KpnI fragment comprising the transglutaminase gene was cloned and inserted into the KpnI restriction site on the pMT23 vector (forming pAE021), followed by sequencing. The 3241 nucleotide sequence of the KpnI fragment is shown in FIG. 2 . The sequence was analyzed with code optimization software provided by GCG, and the gene was predicted to be located at about 700-1900 nucleotides of the KpnI fragment sequence ( FIG. 2 ). The gene is the transglutaminase gene of S. ladaka. The amino acid sequence deduced from the above nucleotide sequence is also shown in Fig. 2, which consists of 410 amino acids and has a molecular weight of 45780.2 Daltons. It is predicted that the mature transglutaminase of S. ladaka starts from the 80th amino acid and consists of 331 amino acids (the underlined area in FIG. 2 ), its molecular weight is 37922.3 Daltons, and its isoelectric point is 7.07.
B.在浅青紫链霉菌中表达拉达卡链轮丝菌的转谷氨酰胺酶基因B. Expression of the transglutaminase gene from S. ladaka in S. lividans
用BglI和BamHI酶切pAE021,纯化所得到的包含转谷氨酰胺酶基因的3.2kb DNA片段并将其插入pIJ702上的BglII酶切位点中,得到pAE051和pAE052(图3A和B)。在浅青紫链霉菌JT46中表达pAE052并每24小时测量上清中的转谷氨酰胺酶活性。在72小时,转化的克隆具有1.46U/ml的最大转谷氨酰胺酶活性(图4)。对胞外培养基进行的拉达卡链轮丝菌转谷氨酰胺酶特异性抗体分析检测到成熟的和未修饰或部分修饰的转谷氨酰胺酶,其分子量在45.8kD和38kD之间分布。上述结果表明浅青紫链霉菌JT46大量表达转谷氨酰胺酶。pAE021 was digested with BglI and BamHI, and the resulting 3.2 kb DNA fragment containing the transglutaminase gene was purified and inserted into the BglII restriction site on pIJ702 to obtain pAE051 and pAE052 (Fig. 3A and B). pAE052 was expressed in S. lividans JT46 and the transglutaminase activity in the supernatant was measured every 24 hours. At 72 hours, the transformed clone had a maximum transglutaminase activity of 1.46 U/ml (Figure 4). Mature and unmodified or partially modified transglutaminases were detected by Streptomyces ladaka transglutaminase-specific antibody analysis of the extracellular medium with a molecular weight distribution between 45.8 kD and 38 kD . The above results indicated that Streptomyces lividans JT46 expressed a large amount of transglutaminase.
序列表Sequence Listing
<110>食品工业发展研究所<110> Food Industry Development Institute
<120>拉达卡链轮丝菌的转谷氨酰胺酶基因及其编码的转谷氨酰胺酶<120> Transglutaminase Gene and Transglutaminase Encoded from Streptothrix ladaka
<130>TKLEE885<130>TKLEE885
<160>3<160>3
<170>PatentIn version 3.1<170>PatentIn version 3.1
<210>1<210>1
<211>1233<211>1233
<212>DNA<212>DNA
<213>拉达卡链轮丝菌<213> Streptotrichum ladaka
<220><220>
<221>CDS<221> CDS
<222>(1)..(1230)<222>(1)..(1230)
<223><223>
<400>1<400>1
atg tcc caa cgc ggg aga act ctc gtc ttc gcc gct ctc ggt gcg gtc 48atg tcc caa cgc ggg aga act ctc gtc ttc gcc gct ctc ggt gcg gtc 48
Met Ser Gln Arg Gly Arg Thr Leu Val Phe Ala Ala Leu Gly Ala ValMet Ser Gln Arg Gly Arg Thr Leu Val Phe Ala Ala Leu Gly Ala Val
1 5 10 151 5 10 15
atg tgc acc acc gcg tta atg ccg tcc gca ggc gcg gcc acc ggc agt 96atg tgc acc acc gcg tta atg ccg tcc gca ggc gcg gcc acc ggc agt 96
Met Cys Thr Thr Ala Leu Met Pro Ser Ala Gly Ala Ala Thr Gly SerMet Cys Thr Thr Ala Leu Met Pro Ser Ala Gly Ala Ala Thr Gly Ser
20 25 3020 25 30
ggc agt ggc agc ggc acc ggg gaa gag aag agg tcc tac gcc gaa acg 144ggc agt ggc agc ggc acc ggg gaa gag aag agg tcc tac gcc gaa acg 144
Gly Ser Gly Ser Gly Thr Gly Glu Glu Lys Arg Ser Tyr Ala Glu ThrGly Ser Gly Ser Gly Thr Gly Glu Glu Lys Arg Ser Tyr Ala Glu Thr
35 40 4535 40 45
cac cgc ctg acg gcg gat gac gtc gac gac atc aac gcg ctg aac gaa 192cac cgc ctg acg gcg gat gac gtc gac gac atc aac gcg ctg aac gaa 192
His Arg Leu Thr Ala Asp Asp Val Asp Asp Ile Asn Ala Leu Asn GluHis Arg Leu Thr Ala Asp Asp Val Asp Asp Ile Asn Ala Leu Asn Glu
50 55 6050 55 60
agc gct ccg gcc gct tcg agc gcc ggt ccg tcc ttc cgg gcc ccc gac 240agc gct ccg gcc gct tcg agc gcc ggt ccg tcc ttc cgg gcc ccc gac 240
Ser Ala Pro Ala Ala Ser Ser Ala Gly Pro Ser Phe Arg Ala Pro AspSer Ala Pro Ala Ala Ser Ser Ala Gly Pro Ser Phe Arg Ala Pro Asp
65 70 75 8065 70 75 80
tcc gac gag cgg gtg act cct ccc gcc gag ccg ctc gac cgg atg ccc 288tcc gac gag cgg gtg act cct ccc gcc gag ccg ctc gac cgg atg ccc 288
Ser Asp Glu Arg Val Thr Pro Pro Ala Glu Pro Leu Asp Arg Met ProSer Asp Glu Arg Val Thr Pro Pro Ala Glu Pro Leu Asp Arg Met Pro
85 90 9585 90 95
gac ccg tac cgg ccc tcg tac ggc agg gcc gag acg atc gtc aac aac 336gac ccg tac cgg ccc tcg tac ggc agg gcc gag acg atc gtc aac aac 336
Asp Pro Tyr Arg Pro Ser Tyr Gly Arg Ala Glu Thr Ile Val Asn AsnAsp Pro Tyr Arg Pro Ser Tyr Gly Arg Ala Glu Thr Ile Val Asn Asn
100 105 110100 105 110
tac ata cgc aag tgg cag cag gtc tac agc cac cgc gac ggc agg aaa 384tac ata cgc aag tgg cag cag gtc tac agc cac cgc gac ggc agg aaa 384
Tyr Ile Arg Lys Trp Gln Gln Val Tyr Ser His Arg Asp Gly Arg LysTyr Ile Arg Lys Trp Gln Gln Val Tyr Ser His Arg Asp Gly Arg Lys
115 120 125115 120 125
cag cag atg acc gag gaa cag cgg gag tgg ctg tcc tac ggt tgc gtc 432cag cag atg acc gag gaa cag cgg gag tgg ctg tcc tac ggt tgc gtc 432
Gln Gln Met Thr Glu Glu Gln Arg Glu Trp Leu Ser Tyr Gly Cys ValGln Gln Met Thr Glu Glu Gln Arg Glu Trp Leu Ser Tyr Gly Cys Val
130 135 140130 135 140
ggt gtc acc tgg gtc aac tcg ggc cag tat ccg acg aac agg ctg gct 480ggt gtc acc tgg gtc aac tcg ggc cag tat ccg acg aac agg ctg gct 480
Gly Val Thr Trp Val Asn Ser Gly Gln Tyr Pro Thr Asn Arg Leu AlaGly Val Thr Trp Val Asn Ser Gly Gln Tyr Pro Thr Asn Arg Leu Ala
145 150 155 160145 150 155 160
ttc gcg ttc ttc gac gag gac aag tac aag aac gag ctg aag aac ggc 528ttc gcg ttc ttc gac gag gac aag tac aag aac gag ctg aag aac ggc 528
Phe Ala Phe Phe Asp Glu Asp Lys Tyr Lys Asn Glu Leu Lys Asn GlyPhe Ala Phe Phe Asp Glu Asp Lys Tyr Lys Asn Glu Leu Lys Asn Gly
165 170 175165 170 175
agg ccc cgg tcc ggc gaa acg cgg gcg gag ttc gag ggg cgc gtc gcc 576agg ccc cgg tcc ggc gaa acg cgg gcg gag ttc gag ggg cgc gtc gcc 576
Arg Pro Arg Ser Gly Glu Thr Arg Ala Glu Phe Glu Gly Arg Val AlaArg Pro Arg Ser Gly Glu Thr Arg Ala Glu Phe Glu Gly Arg Val Ala
180 185 190180 185 190
aag gac agc ttc gac gag gcg aag ggg ttc cag cgg gcg cgt gac gtg 624aag gac agc ttc gac gag gcg aag ggg ttc cag cgg gcg cgt gac gtg 624
Lys Asp Ser Phe Asp Glu Ala Lys Gly Phe Gln Arg Ala Arg Asp ValLys Asp Ser Phe Asp Glu Ala Lys Gly Phe Gln Arg Ala Arg Asp Val
195 200 205195 200 205
gcg tcc gtc atg aac aag gcc ctg gag aac gcc cac gac gag ggg gcg 672gcg tcc gtc atg aac aag gcc ctg gag aac gcc cac gac gag ggg gcg 672
Ala Ser Val Met Asn Lys Ala Leu Glu Asn Ala His Asp Glu Gly AlaAla Ser Val Met Asn Lys Ala Leu Glu Asn Ala His Asp Glu Gly Ala
210 215 220210 215 220
tac ctc gac aac ctc aag aag gag ctg gcg aac ggc aac gac gcc ctg 720tac ctc gac aac ctc aag aag gag ctg gcg aac ggc aac gac gcc ctg 720
Tyr Leu Asp Asn Leu Lys Lys Glu Leu Ala Asn Gly Asn Asp Ala LeuTyr Leu Asp Asn Leu Lys Lys Glu Leu Ala Asn Gly Asn Asp Ala Leu
225 230 235 240225 230 235 240
cgg aac gag gat gcc cgc tcg ccc ttc tac tcg gcg ctg cgg aac acg 768cgg aac gag gat gcc cgc tcg ccc ttc tac tcg gcg ctg cgg aac acg 768
Arg Asn Glu Asp Ala Arg Ser Pro Phe Tyr Ser Ala Leu Arg Asn ThrArg Asn Glu Asp Ala Arg Ser Pro Phe Tyr Ser Ala Leu Arg Asn Thr
245 250 255245 250 255
ccg tcc ttc aag gac cgc aac ggc ggc aat cac gac ccg tcc aag atg 816ccg tcc ttc aag gac cgc aac ggc ggc aat cac gac ccg tcc aag atg 816
Pro Ser Phe Lys Asp Arg Asn Gly Gly Asn His Asp Pro Ser Lys MetPro Ser Phe Lys Asp Arg Asn Gly Gly Asn His Asp Pro Ser Lys Met
260 265 270260 265 270
aag gcc gtc atc tac tcg aag cac ttc tgg agc ggc cag gac cgg tcg 864aag gcc gtc atc tac tcg aag cac ttc tgg agc ggc cag gac cgg tcg 864
Lys Ala Val Ile Tyr Ser Lys His Phe Trp Ser Gly Gln Asp Arg SerLys Ala Val Ile Tyr Ser Lys His Phe Trp Ser Gly Gln Asp Arg Ser
275 280 285275 280 285
ggc tcc tcc gac aag agg aag tac ggc gac ccg gag gcc ttc cgc ccc 912ggc tcc tcc gac aag agg aag tac ggc gac ccg gag gcc ttc cgc ccc 912
Gly Ser Ser Asp Lys Arg Lys Tyr Gly Asp Pro Glu Ala Phe Arg ProGly Ser Ser Asp Lys Arg Lys Tyr Gly Asp Pro Glu Ala Phe Arg Pro
290 295 300290 295 300
gac cgc ggc acc ggc ctg gtc gac atg tcg agg gac agg aac att ccg 960gac cgc ggc acc ggc ctg gtc gac atg tcg agg gac agg aac att ccg 960
Asp Arg Gly Thr Gly Leu Val Asp Met Ser Arg Asp Arg Asn Ile ProAsp Arg Gly Thr Gly Leu Val Asp Met Ser Arg Asp Arg Asn Ile Pro
305 310 315 320305 310 315 320
cgc agc ccc acc agc ccc ggc gag agt ttc gtc aat ttc gsc tac ggc 1008cgc agc ccc acc agc ccc ggc gag agt ttc gtc aat ttc gsc tac ggc 1008
Arg Ser Pro Thr Ser Pro Gly Glu Ser Phe Val Asn Phe Asp Tyr GlyArg Ser Pro Thr Ser Pro Gly Glu Ser Phe Val Asn Phe Asp Tyr Gly
325 330 335325 330 335
tgg ttc gga gcg cag acg gaa gcg gac gcc gsc aag acc gta tgg acc 1056tgg ttc gga gcg cag acg gaa gcg gac gcc gsc aag acc gta tgg acc 1056
Trp Phe Gly Ala Gln Thr Glu Ala Asp Ala Asp Lys Thr Val Trp ThrTrp Phe Gly Ala Gln Thr Glu Ala Asp Ala Asp Lys Thr Val Trp Thr
340 345 350340 345 350
cac ggc aac cac tac cac gcg ccc aat ggc agc ctg ggt gcc atg cac 1104cac ggc aac cac tac cac gcg ccc aat ggc agc ctg ggt gcc atg cac 1104
His Gly Asn His Tyr His Ala Pro Asn Gly Ser Leu Gly Ala Met HisHis Gly Asn His Tyr His Ala Pro Asn Gly Ser Leu Gly Ala Met His
355 360 365355 360 365
gtg tac gag agc aag ttc cgc aac tgg tcc gac ggt tac tcg gac ttc 1152gtg tac gag agc aag ttc cgc aac tgg tcc gac ggt tac tcg gac ttc 1152
Val Tyr Glu Ser Lys Phe Arg Asn Trp Ser Asp Gly Tyr Ser Asp PheVal Tyr Glu Ser Lys Phe Arg Asn Trp Ser Asp Gly Tyr Ser Asp Phe
370 375 380370 375 380
gac cgc gga gcc tac gtg gtc acg ttc gtc ccc aag agc tgg aac acc 1200gac cgc gga gcc tac gtg gtc acg ttc gtc ccc aag agc tgg aac acc 1200
Asp Arg Gly Ala Tyr Val Val Thr Phe Val Pro Lys Ser Trp Asn ThrAsp Arg Gly Ala Tyr Val Val Thr Phe Val Pro Lys Ser Trp Asn Thr
385 390 395 400385 390 395 400
gcc ccc gac aag gtg aca cag ggc tgg ccg tga 1233gcc ccc gac aag gtg aca cag ggc tgg ccg tga 1233
Ala Pro Asp Lys Val Thr Gln Gly Trp ProAla Pro Asp Lys Val Thr Gln Gly Trp Pro
405 410405 410
<210>2<210>2
<211>410<211>410
<212>PRT<212>PRT
<213>拉达卡链轮丝菌<213> Streptotrichum ladaka
<400>2<400>2
Met Ser Gln Arg Gly Arg Thr Leu Val Phe Ala Ala Leu Gly Ala ValMet Ser Gln Arg Gly Arg Thr Leu Val Phe Ala Ala Leu Gly Ala Val
1 5 10 151 5 10 15
Met Cys Thr Thr Ala Leu Met Pro Ser Ala Gly Ala Ala Thr Gly SerMet Cys Thr Thr Ala Leu Met Pro Ser Ala Gly Ala Ala Thr Gly Ser
20 25 3020 25 30
Gly Ser Gly Ser Gly Thr Gly Glu Glu Lys Arg Ser Tyr Ala Glu ThrGly Ser Gly Ser Gly Thr Gly Glu Glu Lys Arg Ser Tyr Ala Glu Thr
35 40 4535 40 45
His Arg Leu Thr Ala Asp Asp Val Asp Asp Ile Asn Ala Leu Asn GluHis Arg Leu Thr Ala Asp Asp Val Asp Asp Ile Asn Ala Leu Asn Glu
50 55 6050 55 60
Ser Ala Pro Ala Ala Ser Ser Ala Gly Pro Ser Phe Arg Ala Pro AspSer Ala Pro Ala Ala Ser Ser Ala Gly Pro Ser Phe Arg Ala Pro Asp
65 70 75 8065 70 75 80
Ser Asp Glu Arg Val Thr Pro Pro Ala Glu Pro Leu Asp Arg Met ProSer Asp Glu Arg Val Thr Pro Pro Ala Glu Pro Leu Asp Arg Met Pro
85 90 9585 90 95
Asp Pro Tyr Arg Pro Ser Tyr Gly Arg Ala Glu Thr Ile Val Asn AsnAsp Pro Tyr Arg Pro Ser Tyr Gly Arg Ala Glu Thr Ile Val Asn Asn
100 105 110100 105 110
Tyr Ile Arg Lys Trp Gln Gln Val Tyr Ser His Arg Asp Gly Arg LysTyr Ile Arg Lys Trp Gln Gln Val Tyr Ser His Arg Asp Gly Arg Lys
115 120 125115 120 125
Gln Gln Met Thr Glu Glu Gln Arg Glu Trp Leu Ser Tyr Gly Cys ValGln Gln Met Thr Glu Glu Gln Arg Glu Trp Leu Ser Tyr Gly Cys Val
130 135 140130 135 140
Gly Val Thr Trp Val Asn Ser Gly Gln Tyr Pro Thr Asn Arg Leu AlaGly Val Thr Trp Val Asn Ser Gly Gln Tyr Pro Thr Asn Arg Leu Ala
145 150 155 160145 150 155 160
Phe Ala Phe Phe Asp Glu Asp Lys Tyr Lys Asn Glu Leu Lys Asn GlyPhe Ala Phe Phe Asp Glu Asp Lys Tyr Lys Asn Glu Leu Lys Asn Gly
165 170 175165 170 175
Arg Pro Arg Ser Gly Glu Thr Arg Ala Glu Phe Glu Gly Arg Val AlaArg Pro Arg Ser Gly Glu Thr Arg Ala Glu Phe Glu Gly Arg Val Ala
180 185 190180 185 190
Lys Asp Ser Phe Asp Glu Ala Lys Gly Phe Gln Arg Ala Arg Asp ValLys Asp Ser Phe Asp Glu Ala Lys Gly Phe Gln Arg Ala Arg Asp Val
195 200 205195 200 205
Ala Ser Val Met Asn Lys Ala Leu Glu Asn Ala His Asp Glu Gly AlaAla Ser Val Met Asn Lys Ala Leu Glu Asn Ala His Asp Glu Gly Ala
210 215 220210 215 220
Tyr Leu Asp Asn Leu Lys Lys Glu Leu Ala Asn Gly Asn Asp Ala LeuTyr Leu Asp Asn Leu Lys Lys Glu Leu Ala Asn Gly Asn Asp Ala Leu
225 230 235 240225 230 235 240
Arg Asn Glu Asp Ala Arg Ser Pro Phe Tyr Ser Ala Leu Arg Asn ThrArg Asn Glu Asp Ala Arg Ser Pro Phe Tyr Ser Ala Leu Arg Asn Thr
245 250 255245 250 255
Pro Ser Phe Lys Asp Arg Asn Gly Gly Asn His Asp Pro Ser Lys MetPro Ser Phe Lys Asp Arg Asn Gly Gly Asn His Asp Pro Ser Lys Met
260 265 270260 265 270
Lys Ala Val Ile Tyr Ser Lys His Phe Trp Ser Gly Gln Asp Arg SerLys Ala Val Ile Tyr Ser Lys His Phe Trp Ser Gly Gln Asp Arg Ser
275 280 285275 280 285
Gly Ser Ser Asp Lys Arg Lys Tyr Gly Asp Pro Glu Ala Phe Arg ProGly Ser Ser Asp Lys Arg Lys Tyr Gly Asp Pro Glu Ala Phe Arg Pro
290 295 300290 295 300
Asp Arg Gly Thr Gly Leu Val Asp Met Ser Arg Asp Arg Asn Ile ProAsp Arg Gly Thr Gly Leu Val Asp Met Ser Arg Asp Arg Asn Ile Pro
305 310 315 320305 310 315 320
Arg Ser Pro Thr Ser Pro Gly Glu Ser Phe Val Asn Phe Asp Tyr GlyArg Ser Pro Thr Ser Pro Gly Glu Ser Phe Val Asn Phe Asp Tyr Gly
325 330 335325 330 335
Trp Phe Gly Ala Gln Thr Glu Ala Asp Ala Asp Lys Thr Val Trp ThrTrp Phe Gly Ala Gln Thr Glu Ala Asp Ala Asp Lys Thr Val Trp Thr
340 345 350340 345 350
His Gly Asn His Tyr His Ala Pro Asn Gly Ser Leu Gly Ala Met HisHis Gly Asn His Tyr His Ala Pro Asn Gly Ser Leu Gly Ala Met His
355 360 365355 360 365
Val Tyr Glu Ser Lys Phe Arg Asn Trp Ser Asp Gly Tyr Ser Asp PheVal Tyr Glu Ser Lys Phe Arg Asn Trp Ser Asp Gly Tyr Ser Asp Phe
370 375 380370 375 380
Asp Arg Gly Ala Tyr Val Val Thr Phe Val Pro Lys Ser Trp Asn ThrAsp Arg Gly Ala Tyr Val Val Thr Phe Val Pro Lys Ser Trp Asn Thr
385 390 395 400385 390 395 400
Ala Pro Asp Lys Val Thr Gln Gly Trp ProAla Pro Asp Lys Val Thr Gln Gly Trp Pro
405 410405 410
<210>3<210>3
<211>644<211>644
<212>DNA<212>DNA
<213>茂原链轮丝菌<213> Streptomyces mobara
<400>3<400>3
ttcgacgagg agaagggctt ccagcgggcg cgtgaggtgg cgtccgtcat gaacagggcc 60ttcgacgagg agaagggctt ccagcgggcg cgtgaggtgg cgtccgtcat gaacagggcc 60
ctggagaacg cccacgacga gagcgcttac ctcgacaacc tcaagaagga actggcgaac 120ctggagaacg cccacgacga gagcgcttac ctcgacaacc tcaagaagga actggcgaac 120
ggcaacgacg ccctgcgcaa cgaagacgcc cgttccccgt tctactcggc gctgcggaac 180ggcaacgacg ccctgcgcaa cgaagacgcc cgttccccgt tctactcggc gctgcggaac 180
acgccgtcct tcaaggagcg gaacggaggc aatcacgacc cgtccaggat gaaggccgtc 240acgccgtcct tcaaggagcg gaacggaggc aatcacgacc cgtccaggat gaaggccgtc 240
atctactcga agcacttctg gagcggccag gaccggtcga gttcggccga caagaggaag 300atctactcga agcacttctg gagcggccag gaccggtcga gttcggccga caagaggaag 300
tacggcgacc cggacgcctt ccgccccgcc ccgggcaccg gcctggtcga catgtcgagg 360tacggcgacc cggacgcctt ccgccccgcc ccgggcaccg gcctggtcga catgtcgagg 360
gacaggaaca ttccgcgcag ccccaccagc cccggtgagg gattcgtcaa tttcgactac 420gacaggaaca ttccgcgcag ccccaccagc cccggtgagg gattcgtcaa tttcgactac 420
ggctggttcg gcgcccagac ggaagcggac gccgacaaga ccgtctggac ccacggaaat 480ggctggttcg gcgccccagac ggaagcggac gccgacaaga ccgtctggac ccacggaaat 480
cactatcacg cgcccaatgg cagcctgggt gccatgcatg tctacgagag caagttccgc 540cactatcacg cgcccaatgg cagcctgggt gccatgcatg tctacgagag caagttccgc 540
aactggtccg agggttactc ggacttcgac cgcggagcct atgtgatcac cttcatcccc 600aactggtccg agggttactc ggacttcgac cgcggagcct atgtgatcac cttcatcccc 600
aagagctgga acaccgcccc cgacaaggta aagcagggct ggcc 644aagagctgga acaccgcccc cgacaaggta aagcagggct ggcc 644
Claims (10)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB011437227A CN100351379C (en) | 2001-12-18 | 2001-12-18 | Transglutaminase Gene and Its Encoded Transglutaminase from Streptomyces ladaka |
HK03109100A HK1056745A1 (en) | 2001-12-18 | 2003-12-13 | Transgulatminase gene of streptovertcillium ladakanum and the transglutaminase encoded therefrom |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB011437227A CN100351379C (en) | 2001-12-18 | 2001-12-18 | Transglutaminase Gene and Its Encoded Transglutaminase from Streptomyces ladaka |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1427078A CN1427078A (en) | 2003-07-02 |
CN100351379C true CN100351379C (en) | 2007-11-28 |
Family
ID=4677233
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB011437227A Expired - Lifetime CN100351379C (en) | 2001-12-18 | 2001-12-18 | Transglutaminase Gene and Its Encoded Transglutaminase from Streptomyces ladaka |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN100351379C (en) |
HK (1) | HK1056745A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101287757A (en) * | 2005-08-18 | 2008-10-15 | 诺沃-诺迪斯克保健股份有限公司 | Transglutaminase variants with improved specificity |
JP2010500886A (en) * | 2006-08-18 | 2010-01-14 | ノボ ノルディスク ヘルス ケア アーゲー | Transglutaminase variants with improved specificity |
CN108841851B (en) * | 2018-07-18 | 2021-12-24 | 中国科学院微生物研究所 | Method for expressing glutamine transaminase by using food-source-safe host |
CN113999862A (en) * | 2020-07-28 | 2022-02-01 | 四川大学 | Heterologous expression of glutamine transaminase and application thereof |
-
2001
- 2001-12-18 CN CNB011437227A patent/CN100351379C/en not_active Expired - Lifetime
-
2003
- 2003-12-13 HK HK03109100A patent/HK1056745A1/en not_active IP Right Cessation
Non-Patent Citations (1)
Title |
---|
Bacterial pro transglutaminase from streptoveticillium mobaraense puification characterisation and sequence of the zymogen.Ralf PASTERNACK 等.Eur J Biochem,Vol.257. 1998 * |
Also Published As
Publication number | Publication date |
---|---|
HK1056745A1 (en) | 2004-02-27 |
CN1427078A (en) | 2003-07-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1372597A (en) | Method for producing L-amino acids by increasing cellular NADPH | |
CN1902221A (en) | Neutralizing epitope-based growth enhancing vaccine | |
CN1177377A (en) | Prodn. of enzymatically active recombinant carboxypeptidase B | |
CN1930299A (en) | Nitrile hydratase of rhodococcus | |
CN1215167C (en) | Helicobacter pylori live vaccine | |
CN1914322A (en) | Cell expansion lethal toxin and detection of bacterium belonging to campylobacter genus that targets the same | |
US6660510B2 (en) | Transglutaminase gene of Streptoverticillium ladakanum and the transglutaminase encoded therefrom | |
CN1336958A (en) | Pyruvate carboxylase from i(Corynebacterium glutamicum) | |
CN100351379C (en) | Transglutaminase Gene and Its Encoded Transglutaminase from Streptomyces ladaka | |
CN1582300A (en) | Gene which codes for novel proteins | |
CN1202244C (en) | Novel protein having aspartase activity and gene DNA coding for the same | |
CN1052509C (en) | Gene encoding polypeptide having nitrile hydratase activity, transformant containing gene and process for production of amides using transformant | |
CN101063113A (en) | Clone and expression for novel phytase | |
CN1250726C (en) | Thermotolerant ribonuclease H | |
CN1289523C (en) | Paddy rice potassium, sodium ion transport gene and its application | |
CN1894272A (en) | Protein expression | |
CN1646690A (en) | Genes coding for glucose-6-phosphate-dehydrogenase proteins | |
CN1239142A (en) | Cytochrome BD type quinol oxidase gene of brevibacterium lactofermentum | |
CN100347294C (en) | Thermostabilized trehasynthetase, coding gene and use thereof | |
CN1084565A (en) | Have the active novel protein of Nitrile hydratase and this proteic gene of coding | |
CN1257269C (en) | A method for producing 7-aminocephalosporanic acid and its special recombinant enzyme | |
CN1303102C (en) | Method for diagnosing and curing alopecia utilizing the Rhor gene of human and rat and the encoding products | |
CN100347298C (en) | Clone of fish muscle growth inhibit or MSTN gene, and establishment of said gene targeting carrier | |
CN1273600C (en) | Coding sequence of Chinese yew tarad-ane C13-lateral chain-N-benzoyl transiting enzymic protein | |
CN1152956C (en) | New hydantoin hydrolase and its application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1056745 Country of ref document: HK |
|
CX01 | Expiry of patent term | ||
CX01 | Expiry of patent term |
Granted publication date: 20071128 |